Goosehead Insurance, Inc (GSHD) Stock Analysis
Is GSHD a good investment?
Goosehead Insurance, Inc (GSHD) has a Plutrex AI rating of 76.0/100 as of September 29, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: PEG of 1.45x is 30% BELOW the insurance broker industry average of 2.07x despite GSHD's next-year EPS growth of 25.1% being 103% ABOVE the industry average of 12.36% — the classic 'growth leader at a discount' setup that institutions pay premiums for. Main concern: CEO transition (headline: 'Goosehead Insurance Announces CEO Transition') is the primary risk — in a franchise-dependent business, leadership change affects franchise recruitment, unit economics, and strategic continuity; the new CEO's capital allocation decisions will be difficult to assess early given the opaque balance sheet (N/A D/E, N/A ROE, negative implied book equity).
Investment Summary
Goosehead Insurance (GSHD) at $44.39 is a high-growth insurance distribution franchise trading at a PEG of 1.45x — 30% below the industry average PEG of 2.07x — despite posting forward EPS growth of 25.1% (next year) and 22.4% (5-year CAGR) that is approximately 2x the insurance broker peer average of 12%. The stock has declined another 14.1% from my prior entry zone of $49.50-$53.50, dropping P/E from 37.67x to 32.34x and PEG from 1.68x to 1.45x. This represents a further valuation improvement that makes GSHD incrementally more attractive on a growth-adjusted basis. Revenue growth of 20.7% YoY and FCF of $82.4M (well above net income of ~$23.7M implied by 8.8% net margin on revenue) confirm operational momentum. However, three structural concerns prevent a higher conviction call: (1) CEO transition announced — leadership uncertainty in a franchise-dependent business is the most material near-term risk; (2) Net margin of 8.78% remains 41% below the industry average of 14.92%, indicating persistent non-operating cost drag; (3) The continued price decline (-14.1% in 7 days from prior report) despite no negative news (Q2 beat + raised guidance) raises questions about technical distribution pressure or undisclosed institutional selling. Analyst consensus target of $69.50 implies 56.6% upside from current price, an unusually wide gap that reflects either deep undervaluation or market skepticism about growth durability through the CEO transition.
Key Strengths
- PEG of 1.45x is 30% BELOW the insurance broker industry average of 2.07x despite GSHD's next-year EPS growth of 25.1% being 103% ABOVE the industry average of 12.36% — the classic 'growth leader at a discount' setup that institutions pay premiums for
- Q2 2026 results confirmed execution: company raised lower end of full-year revenue guidance post-earnings, FCF of $82.4M (3.5x cash balance) confirms high earnings quality, and director insider purchase of ~$100K in shares signals board-level confidence at current prices
- Revenue growth of 20.7% vs. industry 14.75% and TTM earnings growth of 122.2% vs. industry -2.23% demonstrates GSHD is gaining market share while peers contract — structural competitive advantage in insurance distribution franchise model
Key Concerns
- CEO transition (headline: 'Goosehead Insurance Announces CEO Transition') is the primary risk — in a franchise-dependent business, leadership change affects franchise recruitment, unit economics, and strategic continuity; the new CEO's capital allocation decisions will be difficult to assess early given the opaque balance sheet (N/A D/E, N/A ROE, negative implied book equity)
- Stock declined 14.1% in 7 days from prior report ($51.70 → $44.39) with NO negative news (Q2 beat + raised guidance) — this anomalous price action suggests either significant institutional distribution, technical breakdown through key support, or undisclosed macro/sector selling pressure; this technical weakness must be respected and warrants a lower entry zone than pure fundamentals would suggest
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Core valuation: P/E of 32.34x is elevated in isolation but the PEG of 1.45x (using 5-year EPS growth of 22.4%) and implied PEG of ~1.29x (using next-year EPS growth of 25.1%) confirm the stock is not overpriced for its growth profile. For comparison, peers trade at PEG 2.07x on average — GSHD is 30% cheaper on this growth-adjusted metric. Profitability: Operating margin of 23.4% is essentially peer-level (industry: 24.1%), but net margin of 8.78% is 41.2% below the industry average of 14.92%, a -6.14 percentage point gap that signals substantial interest expense or tax drag. The 14.6 pp gap between operating and net margins is the primary profitability concern. FCF of $82.4M substantially exceeds reported net income — a strong cash quality signal indicating high non-cash charges (likely franchise amortization). Health: Cash of $23.7M is modest but FCF generation is robust. D/E ratio is N/A due to implied negative book equity — a structural characteristic of franchise-model businesses but limits leverage assessment. Growth: Revenue +20.7% YoY vs. industry +14.75%; TTM earnings +122.2% vs. industry average -2.23%; next-year EPS growth +25.1% vs. industry +12.36%. GSHD is the unambiguous growth leader across all time horizons.
News Sentiment
Goosehead Insurance is navigating a pivotal moment — the company just reported strong second-quarter 2026 results and promptly raised its full-year revenue outlook, signaling that its franchise model is firing on all cylinders. But a headline about a CEO transition is giving investors reason to pause. The Q2 earnings call (headline: 'Goosehead Insurance Q2 Earnings Call Highlights') confirmed the company is growing faster than its insurance industry peers, with margin expansion alongside revenue growth suggesting the franchise is scaling efficiently. The guidance raise — lifting the lower end of full-year revenue expectations — is exactly the kind of confidence signal that institutional investors want to see. Adding to the positive backdrop, two separate reports highlighted director insider buying: one noting a board member scooped up 1,600 shares, and another confirming a $100,000 purchase (headlines: 'Company Insider Scoops Up 1,600 Shares' and 'Goosehead Insurance Director Buys $100K of Shares'). When company insiders buy stock with their own money at current prices, it's typically a bullish signal — they believe the market is undervaluing the business. The elephant in the room, however, is leadership. The announcement of a CEO transition ('Goosehead Insurance Announces CEO Transition') introduces real uncertainty for a company whose growth depends heavily on franchise relationships and strategic execution. Despite all the positive news, the stock has fallen sharply — which means either the market sees the CEO change as a bigger risk than the strong results suggest, or broader selling pressure is creating a potential buying opportunity for patient investors.
Risk Assessment
PRIMARY RISKS: (1) CEO Transition — most material near-term risk; new leadership in franchise businesses can disrupt recruitment and unit economics; monitor Q3 franchise count and royalty revenue carefully for any deceleration. (2) Technical Momentum Deterioration — stock has declined 25.9% from recent highs ($59.91 → $44.39) with no fundamental deterioration, suggesting either macro-driven sector rotation or institutional exit; a break below $42 (approximate PEG 1.35x support) would signal thesis impairment. (3) Net margin compression — 8.78% vs. 14.92% peer average; if interest rates remain elevated or the new CEO increases leverage, the margin gap could widen further and compress FCF. (4) Growth deceleration risk — P/E of 32.34x leaves limited margin of safety if 22-25% EPS growth disappoints; even a deceleration to 15% growth would imply PEG of 2.16x, well above current price. MITIGATION: Position size kept at 3% to limit exposure to CEO transition uncertainty. Stop at $38.50 represents PEG ~1.25x — a level implying market pricing of material growth deceleration, at which point the thesis is broken. Scale into the position: buy 1.5% now at current prices, add 1.5% if stock finds support above $42.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is GSHD a halal stock?
No, Goosehead Insurance, Inc (GSHD) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for GSHD?
Goosehead Insurance, Inc (GSHD) has a Plutrex AI rating of 76.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is GSHD a good investment?
According to Plutrex AI, GSHD has a Buy rating (76.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in GSHD?
US stocks like GSHD can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in GSHD?
Plutrex AI identifies the main risks for GSHD by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.